| Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice R Tiedt, H Hao-Shen, MA Sobas, R Looser, S Dirnhofer, J Schwaller, ... Blood, The Journal of the American Society of Hematology 111 (8), 3931-3940, 2008 | 525 | 2008 |
| Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms L Arranz, A Sánchez-Aguilera, D Martín-Pérez, J Isern, X Langa, ... Nature 512 (7512), 78-81, 2014 | 467 | 2014 |
| PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers L Brault, C Gasser, F Bracher, K Huber, S Knapp, J Schwaller haematologica 95 (6), 1004-1015, 2010 | 417 | 2010 |
| A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases O Fedorov, B Marsden, V Pogacic, P Rellos, S Müller, AN Bullock, ... Proceedings of the National Academy of Sciences 104 (51), 20523-20528, 2007 | 412 | 2007 |
| Stat5 is essential for the myelo-and lymphoproliferative disease induced by TEL/JAK2 J Schwaller, E Parganas, D Wang, D Cain, JC Aster, IR Williams, CK Lee, ... Molecular cell 6 (3), 693-704, 2000 | 376 | 2000 |
| Programmed death 1 signaling on chronic myeloid leukemia–specific T cells results in T-cell exhaustion and disease progression S Mumprecht, C Schürch, J Schwaller, M Solenthaler, AF Ochsenbein Blood, The Journal of the American Society of Hematology 114 (8), 1528-1536, 2009 | 332 | 2009 |
| Transformation of hematopoietic cell lines to growth‐factor independence and induction of a fatal myelo‐and lymphoproliferative disease in mice by retrovirally transduced TEL … J Schwaller, J Frantsve, J Aster, IR Williams, MH Tomasson, TS Ross, ... The EMBO journal 17 (18), 5321-5333, 1998 | 323 | 1998 |
| Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion AM Paczulla, K Rothfelder, S Raffel, M Konantz, J Steinbacher, H Wang, ... Nature 572 (7768), 254-259, 2019 | 299 | 2019 |
| PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains S Picaud, D Da Costa, A Thanasopoulou, P Filippakopoulos, PV Fish, ... Cancer research 73 (11), 3336-3346, 2013 | 288 | 2013 |
| Generation of a selective small molecule inhibitor of the CBP/p300 bromodomain for leukemia therapy S Picaud, O Fedorov, A Thanasopoulou, K Leonards, K Jones, J Meier, ... Cancer research 75 (23), 5106-5119, 2015 | 239 | 2015 |
| Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation J Frantsve, J Schwaller, DW Sternberg, J Kutok, DG Gilliland Molecular and cellular biology 21 (10), 3547-3557, 2001 | 236 | 2001 |
| Structural analysis identifies imidazo [1, 2-b] pyridazines as PIM kinase inhibitors with in vitro antileukemic activity V Pogacic, AN Bullock, O Fedorov, P Filippakopoulos, C Gasser, A Biondi, ... Cancer research 67 (14), 6916-6924, 2007 | 227 | 2007 |
| MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome V Stavropoulou, S Kaspar, L Brault, MA Sanders, S Juge, S Morettini, ... Cancer cell 30 (1), 43-58, 2016 | 214 | 2016 |
| Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood S Takeuchi, CR Bartram, T Seriu, CW Miller, A Tobler, JW Janssen, ... | 204 | 1995 |
| Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration R Grundler, L Brault, C Gasser, AN Bullock, T Dechow, S Woetzel, ... Journal of experimental medicine 206 (9), 1957-1970, 2009 | 175 | 2009 |
| Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness J Schwaller, P Schneider, P Mhawech-Fauceglia, T McKee, S Myit, ... Blood 109 (1), 331-338, 2007 | 174 | 2007 |
| The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo P Andreasson, J Schwaller, E Anastasiadou, J Aster, DG Gilliland Cancer genetics and cytogenetics 130 (2), 93-104, 2001 | 163 | 2001 |
| Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy D Forte, M García-Fernández, A Sánchez-Aguilera, V Stavropoulou, ... Cell metabolism 32 (5), 829-843. e9, 2020 | 146 | 2020 |
| Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Schwaller, HP Koeffler, G Niklaus, P Loetscher, S Nagel, MF Fey, ... The Journal of clinical investigation 95 (3), 973-979, 1995 | 142 | 1995 |
| H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor β gene in atypical chronic myeloid … J Schwaller, E Anastasiadou, D Cain, J Kutok, S Wojiski, IR Williams, ... Blood, The Journal of the American Society of Hematology 97 (12), 3910-3918, 2001 | 141 | 2001 |
